The large majority of NAFLD patients and a big per
Post# of 148158
Quote:
The large majority of NAFLD patients and a big percentage of NASH patients are asymptomatic and may not want to take weekly injections.
Looking at the effects of leronlimab out to two weeks the formulation could be effective bi-weekly as is for the low level chronic inflammation state of NASH.